Tada et al. have analyzed 51 tumor tissue samples from bladder cancer patients to elucidate whether ABCB1 gene expression and ABCB1 promoter methylation levels were changed during chemotherapeutic treatment [157]. This evidence concerns the gene ABCB1 and urinary bladder cancer.